(Q43754966)

26 November 2017

title

Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study (English)

1 reference

26 November 2017

6

J M Nesland

1 reference

26 November 2017

Z Suo

1

1 reference

26 November 2017

H Yang

2

1 reference

26 November 2017

Q Mei

3

1 reference

26 November 2017

E Skovlund

4

1 reference

26 November 2017

J Cui

5

1 reference

26 November 2017

publication date

1 July 2001

1 reference

International Journal of Surgical Pathology

26 November 2017

published in

1 reference

26 November 2017

volume

9

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

177-187

1 reference

A thousand and one protein kinases

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Triggering signaling cascades by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Receptor protein-tyrosine kinases and their signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

The subcellular localization of the neu protein in human normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Estrogen and progesterone receptors in cytology: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

c-erbB-4 protein expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690100900303

10.1177/106689690100900303

21 January 2018

Identifiers

DOI

1 reference

release_6g2vkycau5ei7jnbxzvqko6xse

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6g2vkycau5ei7jnbxzvqko6xse

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference